Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

The induction of tumor angiogenesis, a pathologic process critical for tumor progression, is mediated by multiple regulatory factors released by tumor and host cells. We investigated the role of the hematopoietic cytokine erythropoietin as an angiogenic factor that modulates tumor progression.Fluore...

Full description

Bibliographic Details
Main Authors: Matthew E Hardee, Yiting Cao, Ping Fu, Xiaohong Jiang, Yulin Zhao, Zahid N Rabbani, Zeljko Vujaskovic, Mark W Dewhirst, Murat O Arcasoy
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-06-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC1891087?pdf=render

Internet

http://europepmc.org/articles/PMC1891087?pdf=render

Similar Items